Two chemically distinct γ-secretase inhibtors, DAPT and LY411, reduce cholesterol levels in cultured human neurons.

“Neuronal γ-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer’s disease.”

Sofia Essayan-Perez and Thomas C. Südhof – Stanford University. Neuron.

This study found that in human neurons, but not mouse glia, γ-secretase regulates the synthesis of cholesterol. Inhibition of γ-secretase reduced cellular cholesterol levels, and all of the genes most affected by loss of γ-secretase function were involved in cholesterol production and trafficking. γ-secretase inhibition affected synaptic transmission in two distinct ways – it reducted vesicle release probability, which was cholesterol-dependent, and increased numbers of synapses, which was cholesterol-independent. Given the outsized role for cholesterol transporter ApoE in determining sporadic AD risk, cholesterol-dependent regulation of synaptic activity may represent a critical pathway through which γ-secretase affects AD pathology.